Clinical trial

Assessment of Endogenous Oxalate Synthesis

NCT05229952

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-02-10

PhaseNA

Study timeline

Study start (actual)2022-02-10Date precision: day

Registry last updated2025-05-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthyunresolved

Kidney Stoneunresolved

Obesityunresolved

Interventions

Low-oxalate controlled dietDIETARY_SUPPLEMENT

Primed, continuous intravenous infusion of 13C2-oxalateOTHER

Sponsors & collaborators

University of Alabama at Birminghamlead sponsor

Mapped research locations

BirminghamAlabama, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05229952 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.